{"disease":{"id":"resistant-brca-wild-type-ovarian-cancer","name":"resistant brca wild type ovarian cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03944902","title":"CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}